Mid-size Medtech
Market Access, Clinical, Marketing & Sales
Launched
Vascular Access
Subscribe to our newsletter to receive the latest case studies.
Mid-size Medtech
Market Access, Clinical, Marketing & Sales
Launched
Vascular Access
The client had recently launched a new technology designed to improve vascular access outcomes for hemodialysis patients.
While clinical benefits were established, adoption depended on how the value was understood by economic decision-makers across providers and payers.
The client engaged Alkemi to define the value landscape and articulate a clear, evidence-based story that could support adoption and reimbursement discussions.
1. Conducted targeted literature reviews to assess complications across the patient journey, site-of-care dynamics, and payment models.
2. Mapped how clinical outcomes translated into economic impact across providers, settings, and quality incentives.
3. Facilitated a cross-functional workshop to align on stakeholder perspectives, value drivers, and evidence gaps.
4. Developed a structured value story and identified priorities for strengthening the evidence base.
Translate clinical improvement into economic value that decision-makers can act on.
“Thank you again for your help to date. The quality, both in terms of work product and process, is remarkable.” - VP, Market Access
The client gained a structured way to communicate value to economic decision-makers.
Teams aligned on value drivers, evidence gaps, and how to position the technology.
A clear value narrative and evidence plan supported more effective market access and adoption discussions.